Global Infection Control in Cancer Therapy Market Insights, Forecast to 2028

Report ID: 1665189 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Infection Control in Cancer Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Radiation Therapy
        1.2.3 Immunotherapy
        1.2.4 Traditional Surgery
        1.2.5 Stem Cell Transplant Therapy
        1.2.6 Chemotherapy
        1.2.7 Targeted Therapy
        1.2.8 Photodynamic Therapy
        1.2.9 Other
    1.3 Market by Application
        1.3.1 Global Infection Control in Cancer Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Pharmaceutical Companies
        1.3.4 Medical device companies
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Infection Control in Cancer Therapy Market Perspective (2017-2028)
    2.2 Infection Control in Cancer Therapy Growth Trends by Region
        2.2.1 Infection Control in Cancer Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Infection Control in Cancer Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Infection Control in Cancer Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Infection Control in Cancer Therapy Market Dynamics
        2.3.1 Infection Control in Cancer Therapy Industry Trends
        2.3.2 Infection Control in Cancer Therapy Market Drivers
        2.3.3 Infection Control in Cancer Therapy Market Challenges
        2.3.4 Infection Control in Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Infection Control in Cancer Therapy Players by Revenue
        3.1.1 Global Top Infection Control in Cancer Therapy Players by Revenue (2017-2022)
        3.1.2 Global Infection Control in Cancer Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Infection Control in Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Infection Control in Cancer Therapy Revenue
    3.4 Global Infection Control in Cancer Therapy Market Concentration Ratio
        3.4.1 Global Infection Control in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Infection Control in Cancer Therapy Revenue in 2021
    3.5 Infection Control in Cancer Therapy Key Players Head office and Area Served
    3.6 Key Players Infection Control in Cancer Therapy Product Solution and Service
    3.7 Date of Enter into Infection Control in Cancer Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Infection Control in Cancer Therapy Breakdown Data by Type
    4.1 Global Infection Control in Cancer Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Infection Control in Cancer Therapy Forecasted Market Size by Type (2023-2028)
5 Infection Control in Cancer Therapy Breakdown Data by Application
    5.1 Global Infection Control in Cancer Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Infection Control in Cancer Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Infection Control in Cancer Therapy Market Size (2017-2028)
    6.2 North America Infection Control in Cancer Therapy Market Size by Type
        6.2.1 North America Infection Control in Cancer Therapy Market Size by Type (2017-2022)
        6.2.2 North America Infection Control in Cancer Therapy Market Size by Type (2023-2028)
        6.2.3 North America Infection Control in Cancer Therapy Market Share by Type (2017-2028)
    6.3 North America Infection Control in Cancer Therapy Market Size by Application
        6.3.1 North America Infection Control in Cancer Therapy Market Size by Application (2017-2022)
        6.3.2 North America Infection Control in Cancer Therapy Market Size by Application (2023-2028)
        6.3.3 North America Infection Control in Cancer Therapy Market Share by Application (2017-2028)
    6.4 North America Infection Control in Cancer Therapy Market Size by Country
        6.4.1 North America Infection Control in Cancer Therapy Market Size by Country (2017-2022)
        6.4.2 North America Infection Control in Cancer Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Infection Control in Cancer Therapy Market Size (2017-2028)
    7.2 Europe Infection Control in Cancer Therapy Market Size by Type
        7.2.1 Europe Infection Control in Cancer Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Infection Control in Cancer Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Infection Control in Cancer Therapy Market Share by Type (2017-2028)
    7.3 Europe Infection Control in Cancer Therapy Market Size by Application
        7.3.1 Europe Infection Control in Cancer Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Infection Control in Cancer Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Infection Control in Cancer Therapy Market Share by Application (2017-2028)
    7.4 Europe Infection Control in Cancer Therapy Market Size by Country
        7.4.1 Europe Infection Control in Cancer Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Infection Control in Cancer Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Infection Control in Cancer Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type
        8.2.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Infection Control in Cancer Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application
        8.3.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Infection Control in Cancer Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region
        8.4.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Infection Control in Cancer Therapy Market Size (2017-2028)
    9.2 Latin America Infection Control in Cancer Therapy Market Size by Type
        9.2.1 Latin America Infection Control in Cancer Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Infection Control in Cancer Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Infection Control in Cancer Therapy Market Share by Type (2017-2028)
    9.3 Latin America Infection Control in Cancer Therapy Market Size by Application
        9.3.1 Latin America Infection Control in Cancer Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Infection Control in Cancer Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Infection Control in Cancer Therapy Market Share by Application (2017-2028)
    9.4 Latin America Infection Control in Cancer Therapy Market Size by Country
        9.4.1 Latin America Infection Control in Cancer Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Infection Control in Cancer Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Infection Control in Cancer Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type
        10.2.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Infection Control in Cancer Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application
        10.3.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Infection Control in Cancer Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country
        10.4.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Kimberly Clark Corporation
        11.1.1 Kimberly Clark Corporation Company Details
        11.1.2 Kimberly Clark Corporation Business Overview
        11.1.3 Kimberly Clark Corporation Infection Control in Cancer Therapy Introduction
        11.1.4 Kimberly Clark Corporation Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.1.5 Kimberly Clark Corporation Recent Developments
    11.2 3M Healthcare Company
        11.2.1 3M Healthcare Company Company Details
        11.2.2 3M Healthcare Company Business Overview
        11.2.3 3M Healthcare Company Infection Control in Cancer Therapy Introduction
        11.2.4 3M Healthcare Company Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.2.5 3M Healthcare Company Recent Developments
    11.3 Honeywell International, Inc.
        11.3.1 Honeywell International, Inc. Company Details
        11.3.2 Honeywell International, Inc. Business Overview
        11.3.3 Honeywell International, Inc. Infection Control in Cancer Therapy Introduction
        11.3.4 Honeywell International, Inc. Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.3.5 Honeywell International, Inc. Recent Developments
    11.4 Getinge Group AB
        11.4.1 Getinge Group AB Company Details
        11.4.2 Getinge Group AB Business Overview
        11.4.3 Getinge Group AB Infection Control in Cancer Therapy Introduction
        11.4.4 Getinge Group AB Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.4.5 Getinge Group AB Recent Developments
    11.5 Sterigenics International
        11.5.1 Sterigenics International Company Details
        11.5.2 Sterigenics International Business Overview
        11.5.3 Sterigenics International Infection Control in Cancer Therapy Introduction
        11.5.4 Sterigenics International Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.5.5 Sterigenics International Recent Developments
    11.6 Sakura Global Holding Company
        11.6.1 Sakura Global Holding Company Company Details
        11.6.2 Sakura Global Holding Company Business Overview
        11.6.3 Sakura Global Holding Company Infection Control in Cancer Therapy Introduction
        11.6.4 Sakura Global Holding Company Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.6.5 Sakura Global Holding Company Recent Developments
    11.7 Arizant Healthcare Inc.
        11.7.1 Arizant Healthcare Inc. Company Details
        11.7.2 Arizant Healthcare Inc. Business Overview
        11.7.3 Arizant Healthcare Inc. Infection Control in Cancer Therapy Introduction
        11.7.4 Arizant Healthcare Inc. Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.7.5 Arizant Healthcare Inc. Recent Developments
    11.8 Nordion
        11.8.1 Nordion Company Details
        11.8.2 Nordion Business Overview
        11.8.3 Nordion Infection Control in Cancer Therapy Introduction
        11.8.4 Nordion Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.8.5 Nordion Recent Developments
    11.9 Cisa S.P.A.
        11.9.1 Cisa S.P.A. Company Details
        11.9.2 Cisa S.P.A. Business Overview
        11.9.3 Cisa S.P.A. Infection Control in Cancer Therapy Introduction
        11.9.4 Cisa S.P.A. Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.9.5 Cisa S.P.A. Recent Developments
    11.10 Steris Corporation
        11.10.1 Steris Corporation Company Details
        11.10.2 Steris Corporation Business Overview
        11.10.3 Steris Corporation Infection Control in Cancer Therapy Introduction
        11.10.4 Steris Corporation Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.10.5 Steris Corporation Recent Developments
    11.11 Nordion, Inc.
        11.11.1 Nordion, Inc. Company Details
        11.11.2 Nordion, Inc. Business Overview
        11.11.3 Nordion, Inc. Infection Control in Cancer Therapy Introduction
        11.11.4 Nordion, Inc. Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.11.5 Nordion, Inc. Recent Developments
    11.12 Ahlstrom Filtration LLC
        11.12.1 Ahlstrom Filtration LLC Company Details
        11.12.2 Ahlstrom Filtration LLC Business Overview
        11.12.3 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Introduction
        11.12.4 Ahlstrom Filtration LLC Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.12.5 Ahlstrom Filtration LLC Recent Developments
    11.13 Membrana GmbH
        11.13.1 Membrana GmbH Company Details
        11.13.2 Membrana GmbH Business Overview
        11.13.3 Membrana GmbH Infection Control in Cancer Therapy Introduction
        11.13.4 Membrana GmbH Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.13.5 Membrana GmbH Recent Developments
    11.14 Synergy Health, Plc
        11.14.1 Synergy Health, Plc Company Details
        11.14.2 Synergy Health, Plc Business Overview
        11.14.3 Synergy Health, Plc Infection Control in Cancer Therapy Introduction
        11.14.4 Synergy Health, Plc Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.14.5 Synergy Health, Plc Recent Developments
    11.15 Advanced Sterilization Products Services, Inc
        11.15.1 Advanced Sterilization Products Services, Inc Company Details
        11.15.2 Advanced Sterilization Products Services, Inc Business Overview
        11.15.3 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Introduction
        11.15.4 Advanced Sterilization Products Services, Inc Revenue in Infection Control in Cancer Therapy Business (2017-2022)
        11.15.5 Advanced Sterilization Products Services, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Infection Control in Cancer Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Radiation Therapy
    Table 3. Key Players of Immunotherapy
    Table 4. Key Players of Traditional Surgery
    Table 5. Key Players of Stem Cell Transplant Therapy
    Table 6. Key Players of Chemotherapy
    Table 7. Key Players of Targeted Therapy
    Table 8. Key Players of Photodynamic Therapy
    Table 9. Key Players of Other
    Table 10. Global Infection Control in Cancer Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Infection Control in Cancer Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Infection Control in Cancer Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Infection Control in Cancer Therapy Market Share by Region (2017-2022)
    Table 14. Global Infection Control in Cancer Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Infection Control in Cancer Therapy Market Share by Region (2023-2028)
    Table 16. Infection Control in Cancer Therapy Market Trends
    Table 17. Infection Control in Cancer Therapy Market Drivers
    Table 18. Infection Control in Cancer Therapy Market Challenges
    Table 19. Infection Control in Cancer Therapy Market Restraints
    Table 20. Global Infection Control in Cancer Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Infection Control in Cancer Therapy Revenue Share by Players (2017-2022)
    Table 22. Global Top Infection Control in Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Control in Cancer Therapy as of 2021)
    Table 23. Ranking of Global Top Infection Control in Cancer Therapy Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Infection Control in Cancer Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Infection Control in Cancer Therapy Product Solution and Service
    Table 27. Date of Enter into Infection Control in Cancer Therapy Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Infection Control in Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Infection Control in Cancer Therapy Revenue Market Share by Type (2017-2022)
    Table 31. Global Infection Control in Cancer Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Infection Control in Cancer Therapy Revenue Market Share by Type (2023-2028)
    Table 33. Global Infection Control in Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Infection Control in Cancer Therapy Revenue Share by Application (2017-2022)
    Table 35. Global Infection Control in Cancer Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Infection Control in Cancer Therapy Revenue Share by Application (2023-2028)
    Table 37. North America Infection Control in Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Infection Control in Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Infection Control in Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Infection Control in Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Infection Control in Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Infection Control in Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Infection Control in Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Infection Control in Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Infection Control in Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Infection Control in Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Infection Control in Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Infection Control in Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Infection Control in Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Infection Control in Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Infection Control in Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Infection Control in Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Infection Control in Cancer Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Infection Control in Cancer Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Infection Control in Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Infection Control in Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Infection Control in Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Infection Control in Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Infection Control in Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Infection Control in Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Infection Control in Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Infection Control in Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Infection Control in Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Infection Control in Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Infection Control in Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Infection Control in Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Kimberly Clark Corporation Company Details
    Table 68. Kimberly Clark Corporation Business Overview
    Table 69. Kimberly Clark Corporation Infection Control in Cancer Therapy Product
    Table 70. Kimberly Clark Corporation Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 71. Kimberly Clark Corporation Recent Developments
    Table 72. 3M Healthcare Company Company Details
    Table 73. 3M Healthcare Company Business Overview
    Table 74. 3M Healthcare Company Infection Control in Cancer Therapy Product
    Table 75. 3M Healthcare Company Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 76. 3M Healthcare Company Recent Developments
    Table 77. Honeywell International, Inc. Company Details
    Table 78. Honeywell International, Inc. Business Overview
    Table 79. Honeywell International, Inc. Infection Control in Cancer Therapy Product
    Table 80. Honeywell International, Inc. Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 81. Honeywell International, Inc. Recent Developments
    Table 82. Getinge Group AB Company Details
    Table 83. Getinge Group AB Business Overview
    Table 84. Getinge Group AB Infection Control in Cancer Therapy Product
    Table 85. Getinge Group AB Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 86. Getinge Group AB Recent Developments
    Table 87. Sterigenics International Company Details
    Table 88. Sterigenics International Business Overview
    Table 89. Sterigenics International Infection Control in Cancer Therapy Product
    Table 90. Sterigenics International Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 91. Sterigenics International Recent Developments
    Table 92. Sakura Global Holding Company Company Details
    Table 93. Sakura Global Holding Company Business Overview
    Table 94. Sakura Global Holding Company Infection Control in Cancer Therapy Product
    Table 95. Sakura Global Holding Company Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 96. Sakura Global Holding Company Recent Developments
    Table 97. Arizant Healthcare Inc. Company Details
    Table 98. Arizant Healthcare Inc. Business Overview
    Table 99. Arizant Healthcare Inc. Infection Control in Cancer Therapy Product
    Table 100. Arizant Healthcare Inc. Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 101. Arizant Healthcare Inc. Recent Developments
    Table 102. Nordion Company Details
    Table 103. Nordion Business Overview
    Table 104. Nordion Infection Control in Cancer Therapy Product
    Table 105. Nordion Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 106. Nordion Recent Developments
    Table 107. Cisa S.P.A. Company Details
    Table 108. Cisa S.P.A. Business Overview
    Table 109. Cisa S.P.A. Infection Control in Cancer Therapy Product
    Table 110. Cisa S.P.A. Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 111. Cisa S.P.A. Recent Developments
    Table 112. Steris Corporation Company Details
    Table 113. Steris Corporation Business Overview
    Table 114. Steris Corporation Infection Control in Cancer Therapy Product
    Table 115. Steris Corporation Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 116. Steris Corporation Recent Developments
    Table 117. Nordion, Inc. Company Details
    Table 118. Nordion, Inc. Business Overview
    Table 119. Nordion, Inc. Infection Control in Cancer Therapy Product
    Table 120. Nordion, Inc. Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 121. Nordion, Inc. Recent Developments
    Table 122. Ahlstrom Filtration LLC Company Details
    Table 123. Ahlstrom Filtration LLC Business Overview
    Table 124. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Product
    Table 125. Ahlstrom Filtration LLC Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 126. Ahlstrom Filtration LLC Recent Developments
    Table 127. Membrana GmbH Company Details
    Table 128. Membrana GmbH Business Overview
    Table 129. Membrana GmbH Infection Control in Cancer Therapy Product
    Table 130. Membrana GmbH Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 131. Membrana GmbH Recent Developments
    Table 132. Synergy Health, Plc Company Details
    Table 133. Synergy Health, Plc Business Overview
    Table 134. Synergy Health, Plc Infection Control in Cancer Therapy Product
    Table 135. Synergy Health, Plc Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 136. Synergy Health, Plc Recent Developments
    Table 137. Advanced Sterilization Products Services, Inc Company Details
    Table 138. Advanced Sterilization Products Services, Inc Business Overview
    Table 139. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Product
    Table 140. Advanced Sterilization Products Services, Inc Revenue in Infection Control in Cancer Therapy Business (2017-2022) & (US$ Million)
    Table 141. Advanced Sterilization Products Services, Inc Recent Developments
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infection Control in Cancer Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Radiation Therapy Features
    Figure 3. Immunotherapy Features
    Figure 4. Traditional Surgery Features
    Figure 5. Stem Cell Transplant Therapy Features
    Figure 6. Chemotherapy Features
    Figure 7. Targeted Therapy Features
    Figure 8. Photodynamic Therapy Features
    Figure 9. Other Features
    Figure 10. Global Infection Control in Cancer Therapy Market Share by Application: 2021 VS 2028
    Figure 11. Hospital Case Studies
    Figure 12. Pharmaceutical Companies Case Studies
    Figure 13. Medical device companies Case Studies
    Figure 14. Other Case Studies
    Figure 15. Infection Control in Cancer Therapy Report Years Considered
    Figure 16. Global Infection Control in Cancer Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Infection Control in Cancer Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Infection Control in Cancer Therapy Market Share by Region: 2021 VS 2028
    Figure 19. Global Infection Control in Cancer Therapy Market Share by Players in 2021
    Figure 20. Global Top Infection Control in Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Control in Cancer Therapy as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Infection Control in Cancer Therapy Revenue in 2021
    Figure 22. North America Infection Control in Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. North America Infection Control in Cancer Therapy Market Size Market Share by Type (2017-2028)
    Figure 24. North America Infection Control in Cancer Therapy Market Size Market Share by Application (2017-2028)
    Figure 25. North America Infection Control in Cancer Therapy Market Size Share by Country (2017-2028)
    Figure 26. United States Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Canada Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Europe Infection Control in Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 29. Europe Infection Control in Cancer Therapy Market Size Market Share by Type (2017-2028)
    Figure 30. Europe Infection Control in Cancer Therapy Market Size Market Share by Application (2017-2028)
    Figure 31. Europe Infection Control in Cancer Therapy Market Size Share by Country (2017-2028)
    Figure 32. Germany Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. France Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. U.K. Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Italy Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Russia Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Nordic Countries Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Infection Control in Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 39. Asia Pacific Infection Control in Cancer Therapy Market Size Market Share by Type (2017-2028)
    Figure 40. Asia Pacific Infection Control in Cancer Therapy Market Size Market Share by Application (2017-2028)
    Figure 41. Asia Pacific Infection Control in Cancer Therapy Market Size Share by Region (2017-2028)
    Figure 42. China Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Japan Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. South Korea Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Southeast Asia Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. India Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Australia Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 48. Latin America Infection Control in Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Latin America Infection Control in Cancer Therapy Market Size Market Share by Type (2017-2028)
    Figure 50. Latin America Infection Control in Cancer Therapy Market Size Market Share by Application (2017-2028)
    Figure 51. Latin America Infection Control in Cancer Therapy Market Size Share by Country (2017-2028)
    Figure 52. Mexico Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Brazil Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Infection Control in Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 55. Middle East and Africa Infection Control in Cancer Therapy Market Size Market Share by Type (2017-2028)
    Figure 56. Middle East and Africa Infection Control in Cancer Therapy Market Size Market Share by Application (2017-2028)
    Figure 57. Middle East and Africa Infection Control in Cancer Therapy Market Size Share by Country (2017-2028)
    Figure 58. Turkey Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Saudi Arabia Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. UAE Infection Control in Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Kimberly Clark Corporation Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 62. 3M Healthcare Company Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 63. Honeywell International, Inc. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 64. Getinge Group AB Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 65. Sterigenics International Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 66. Sakura Global Holding Company Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 67. Arizant Healthcare Inc. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 68. Nordion Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 69. Cisa S.P.A. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 70. Steris Corporation Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 71. Nordion, Inc. Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 72. Ahlstrom Filtration LLC Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 73. Membrana GmbH Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 74. Synergy Health, Plc Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 75. Advanced Sterilization Products Services, Inc Revenue Growth Rate in Infection Control in Cancer Therapy Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Kimberly Clark Corporation
3M Healthcare Company
Honeywell International, Inc.
Getinge Group AB
Sterigenics International
Sakura Global Holding Company
Arizant Healthcare Inc.
Nordion
Cisa S.P.A.
Steris Corporation
Nordion, Inc.
Ahlstrom Filtration LLC
Membrana GmbH
Synergy Health, Plc
Advanced Sterilization Products Services, Inc
Frequently Asked Questions
Infection Control in Cancer Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Infection Control in Cancer Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Infection Control in Cancer Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mercury (I) Sulphate

Mercury (I) Sulphate market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Optogenetics

Optogenetics market is segmented by players, region (country), by Type and by Application. Player ... Read More